Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
SHANGHAI PHARMATECHS CO.LTD
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership
2016-11-23 08:00
WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors
2016-09-22 20:00
Innovative Biotech Company CStone Pharmaceuticals Receives 150 million Dollars in Series A Financing to Focus on Addressing the Specific Needs of Chinese Patients
2016-07-04 08:00
WuXi AppTec's Pharmaceutical Development Service and Analytical Service Passes EMA Inspection
2016-05-12 08:00
WuXi Healthcare Ventures Appoints Renowned Life Science Entrepreneur, Gregory Verdine, Ph.D. as newest Venture Partner
2016-05-03 20:00
LabNetwork Forges eCommerce Alliances with Leading Chemical Providers
2016-04-27 16:18
LabNetwork Announces Groundbreaking eCommerce Alliances
2016-04-26 14:00
WuXi AppTec Acquires Crelux
2016-04-15 15:00
WuXi AppTec Lab Testing Division's Analytical and Stability Testing Facilities Passed FDA Inspection
2016-04-11 20:00
Juno Therapeutics and WuXi AppTec Announce New Company to Develop Novel Cell-Based Cancer Immunotherapies in China
2016-04-08 04:30
WuXi Biologics Congratulates Ambrx and ZMC for Successful Dosing of a Novel Antibody-Drug Conjugate in Australia
2016-03-25 20:30
WuXi AppTec Launches South Korea Branch
2016-03-25 20:00
WuXi AppTec's STA Subsidiary Opens New Campus in Changzhou
2016-03-04 21:00
Prima BioMed and WuXi Biologics Announce First Dose of Chinese-Manufactured Biologic in EU Clinical Trial
2016-03-02 14:00
WuXi AppTec Releases New Mobile App for Compounds Sourcing
2016-02-18 21:00
WuXi AppTec Congratulates MSD on Receiving FDA Approval of ZEPATIER(TM)
2016-02-03 09:35
WuXi Healthcare Ventures Joins Financing Rounds for Twist Bioscience and Syros Pharmaceuticals
2016-01-22 21:00
WuXi AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic
2016-01-08 21:00
WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement
2016-01-08 21:00
WuXi AppTec Denies Issuing Press Release Regarding Great Basin Scientific
2015-12-24 00:36
1
4
5
6
7
8
19